Changshu, China

Xizhou Lv

This inventor holds 1 USPTO granted patent. Top assignee: Scinopharm (Changshu) Pharmaceuticals, Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xizhou Lv. Retrieved from https://idiyas.com/inventor/xizhou-lv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xizhou Lv: Innovator in Quinazoline Derivatives

Introduction

Xizhou Lv is a notable inventor based in Changshu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for synthesizing important chemical compounds.

Latest Patents

Xizhou Lv holds a patent for a process of preparing a quinazoline derivative. This innovative method is described as a concise, efficient, and cost- and time-saving approach for the preparation of a quinazoline derivative, which serves as an intermediate for making gefitinib or gefitinib itself. The process involves reacting a compound of Formula B with 3-chloro-4-fluoroaniline in the presence of a N,N-dialkyl formamide acetal, a Bronsted acid catalyst, and a solvent in a one-pot reaction. He has 1 patent to his name.

Career Highlights

Xizhou Lv is currently employed at Scinopharm (Changshu) Pharmaceuticals, Ltd., where he continues to work on innovative pharmaceutical solutions. His expertise in chemical processes has positioned him as a valuable asset in the industry.

Collaborations

Xizhou collaborates with Xiaoheng Zhang, contributing to advancements in their field through shared knowledge and expertise.

Conclusion

Xizhou Lv's work in the preparation of quinazoline derivatives showcases his innovative spirit and dedication to pharmaceutical advancements. His contributions are significant in the ongoing development of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…